Tourmaline Bio Inc.

NASDAQ: TRML · Real-Time Price · USD
22.50
0.11 (0.49%)
At close: Aug 15, 2025, 3:59 PM
22.13
-1.62%
After-hours: Aug 15, 2025, 05:03 PM EDT

Tourmaline Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-88.47M -82.87M -73.21M -48.85M -34.26M -32.91M -27.1M -29.23M -42.65M -44.61M -55.37M -69.61M -63.54M -56.79M -47.83M -40.37M -33.85M -27.16M
Depreciation & Amortization
43K 41K 39K 41K 40K 37K 33K 22K 609K 1.2M 1.68M 1.86M 1.44M 976K 623K 560K 522K 490K
Stock-Based Compensation
8.15M 7.48M 6.59M 9.11M 8.14M 6.35M 4.96M 707K 1K 588.00 195.00 n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
4.13M 3.65M -903K -2.86M -5.33M -4.85M -2.17M -296.17K 2.4M 751.32K -712.95K 1.39M 792K 800K 992K -939K -1.63M 941K
Other Non-Cash Items
-9.9M -12.54M -12.22M -7.36M -534K 10.62M 11.85M 8.93M 12.94M 8.81M 11.2M 11.47M 9.18M 5.82M 4.79M 5.35M 4.06M 2.75M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
3.9M 3.87M 1.53M 1.71M -685K -3.35M 1.74M 30.05K 2.84M 3.06M -927.95K 2.29M 1.53M 2.88M 2.31M -723K -1.24M 904K
Operating Cash Flow
-86.28M -84.02M -77.26M -45.35M -27.3M -18.84M -7.71M -18.73M -26.76M -34.5M -46.99M -56.82M -53.52M -47.22M -39.99M -35.81M -30.5M -23.02M
Capital Expenditures
-25K -18K -9K n/a -504K -517K -541K -2.83M -2.67M -3.75M -5.07M -3.96M -4.35M -3.59M -2.44M -1.5M -1.11M -1.12M
Cash Acquisitions
n/a n/a n/a -650K -650K -650K -650K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-233.35M -235.43M -366.14M -277.89M -189.85M -196.68M -6.08M -125.62M -178.23M -176.87M -191.58M -205.68M -189.02M -281.56M -275.88M -317.9M -309.98M -173.43M
Sales Maturities Of Investments
280.32M 255.95M 171.84M -21.05M -97.4M -71.3M -45.3M 171.77M 231.02M 241.54M 250.29M 257.02M 236.14M 207.87M 181.93M 117.93M 94.88M 62.04M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a -5K -5K -5K -5K n/a n/a -1K -1K -1K
Investing Cash Flow
46.94M 20.5M -194.31M -299.11M -287.44M -277.32M -88.47M -54.05K 6.27M 26.21M 46.66M 47.38M 42.77M -77.29M -96.39M -201.47M -216.21M -112.52M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-11K -11K -4K 4K 5K n/a n/a -5K -5K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
54K n/a n/a 85.99M 82.37M 82.46M 82.46M -3.53M 92.2K n/a n/a n/a n/a -277K -277K -277K -277K n/a
Financial Cash Flow
612K 558K 161.35M 317.81M 314.19M 406.39M 245.09M 88.68M 92.38M 258K 242K 594K -30K 137.41M 137.4M 136.46M 268.64M 131.14M
Net Cash Flow
-38.73M -62.96M -110.22M -31.85M 52.02M 162.81M 201.43M 127.56M 71.78M -8.14M -150.55K -8.84M -10.78M -13.51M -17.68M -8.99M n/a n/a
Free Cash Flow
-86.3M -84.04M -77.27M -45.35M -48.18M -39.73M -28.62M -41.94M -29.44M -38.25M -52.06M -60.78M -57.87M -50.81M -42.42M -37.3M -31.62M -24.14M